<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Special Considerations, Incentives, and Programs To Support the Approval of New Animal Drugs for Minor Uses and for Minor Species; Draft Guidance for Industry; Availability; Extension of Comment Period</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Special Considerations, Incentives, and Programs To Support the Approval of New Animal Drugs for Minor Uses and for Minor Species; Draft Guidance for Industry; Availability; Extension of Comment Period</h1>
    <p class="timestamp">Published: 2020-11-10 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or the Agency) is extending the comment period for the notice of availability that appeared in the Federal Register of July 15, 2020. In that notice, FDA requested comments on draft guidance for industry (GFI) #61 entitled "Special Considerations, Incentives, and Programs to Support the Approval of New Animal Drugs for Minor Uses and for Minor Species." FDA is taking this action in response to a request for an extension to allow interested persons additional...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2020-24970</p>
    <p><strong>Publication Date:</strong> 2020-11-10</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2020/11/10/2020-24970/special-considerations-incentives-and-programs-to-support-the-approval-of-new-animal-drugs-for-minor">https://www.federalregister.gov/documents/2020/11/10/2020-24970/special-considerations-incentives-and-programs-to-support-the-approval-of-new-animal-drugs-for-minor</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2020-24970</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
